PF-Atlas › Clinical Trials › NCT00812045
Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
AZD1236 · Phase 2
Registry ID
NCT00812045
Phase
Phase 2
Status
Withdrawn
Drug / intervention
AZD1236
Sponsor
AstraZeneca
Start
2009-12
About this trial
AZD1236 is evaluated in NCT00812045, a Phase 2 idiopathic pulmonary fibrosis study sponsored by AstraZeneca. Current status: Withdrawn.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00812045 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.